{"artifact_id":"open_question-6a87e29a-b4de-4c9d-9bea-4ce55761fc16","artifact_type":"open_question","title":"Which molecular signatures distinguish reversible nigral dysfunction from irreversible neuronal loss in early CBD/CBS?","quality_score":0.5,"is_latest":1,"version_number":4,"version_count":1,"debate_count":0,"supports_count":0,"contradicts_count":0,"neutral_count":0,"incoming_by_type":{},"total_incoming":0,"outgoing_by_type":{"derives_from":1},"total_outgoing":1,"quality_trajectory":[{"score":0.5,"at":"2026-05-16T14:51:34.657673-07:00"},{"score":0.5,"at":"2026-05-16T08:03:22.955306-07:00"},{"score":0.5,"at":"2026-04-28T03:48:49.857966-07:00"},{"score":0.5,"at":"2026-04-26T23:44:36.179837-07:00"}],"evidence_balance":0.0,"evidence_certainty":0.0,"total_evidence_items":1,"is_well_supported":false,"is_controversial":false,"is_foundational":false}